Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Top 3 Australian IPOs from 2019

With the ASX struggling on the final day of the 2019 calendar year, we take a look at three of the most successful companies to IPO over the last year.

Top three ASX IPOs 2019 Source: Bloomberg

Best ASX IPOs of 2019

It’s been an up and down year for Australian IPOs – with a number of companies listing to significant fanfare – while others, like Prospa Group (ASX: PGL) have faced an investor exodus.

Ultimately, with the ASX 200 itself rising more than 20% in 2019—it has generally speaking—been a good time to be in equities. Whether this bullishness will hold into 2020 however, is another matter entirely.

With all this in mind, below we examine the three best performing IPOs of the 2019 calendar year.

Osteopore share price: +265%

Osteopore (ASX: OSX) is centrally involved in the commercialisation ‘of patented 3D printed bioresorbable products, specifically engineered to facilitate natural bone healing.’

Through the company’s IPO – held in September 2019 – Osteopore raised $5.25m to further its health-focused ambitions. The company intends to use these funds to increase market penetration in the Asian region, further refine its current sales and distribution networks in the US and EU, and secure additional regulatory clearances (Australian TGA approval, for example) – among other uses.

Positively, the company is currently revenue positive, reporting revenue from the September quarter of $298,000 – on a market capitalisation of $73.9m.

At an issue price of $0.20 per share, the Osteopore share price, which currently trades around the $0.73 mark, is currently up around 265%.

Splitit share price: +229%

Likely buoyed by general optimism around the buy now pay later (BNPL) space, Splitit’s (ASX: SPT) share price currently trades some 229% ahead of its IPO issue price.

Some of the company’s key financial figures may help to explain this meteoric run-up since listing.

As part of the company’s latest investor presentation, for example, it was revealed that for the six months ending June 30, Splitit’s revenue had reached $1.14m – a 293% increase on a PCP basis. Profitability also improved in that period, with the company revealing gross profits of $1.03m, a 550% increase on a PCP basis.

Other operational metrics have also likely contributed to bullishness around the stock: Q3 FY19 figures revealed 634 merchants and 235,000 customers were using Splitit’s BNPL payment solutions.

Uniti Wireless share price: + 532%

Operating in the presumed slow-moving telecommunications sector, since listing in February 2019, Uniti Wireless (ASX: UWL) has gone on a spending spree, finalising eight 'accretive acquisitions’, including: Fuzenet, Pivit, Clublinks, Fone Dynamics, Call Dynamics, LBNCo, Open Networks and most recently 1300 AUSTRALIA.

Not only strategically focused, the company met its pro-forma prospectus forecast for FY19, and as the company recently wrote: 'Pro-forma FY20 EBITDA (F) is now in excess of $32 million.' Just as importantly, the company has around $30m in cash on hand after a recently completed capital raise.

Speaking of the company’s ambitions a little more than a year ago, the Uniti Wireless’s co-founder and CEO, Che Metcalfe said:

‘We wanted to build a $100 million company, but now there’s real potential that we can build a half a billion or a billion-dollar company.’

With a current market capitalisation of $506m, the company has thus far made good progress on the upper-end of such an ambition.

Practise trading Australian stocks with an IG demo account now

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.